Mahrou Vahabi Selected Research

Pancreatic Neoplasms (Pancreatic Cancer)

2/2024	Pharmacological mechanisms underlying the interaction of the nucleoside analogue gemcitabine with the c-MET inhibitor tivantinib in pancreatic cancer.
12/2023	Thinking small to win big? A critical review on the potential application of extracellular vesicles for biomarker discovery and new therapeutic approaches in pancreatic cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mahrou Vahabi Research Topics

Disease

6	Neoplasms (Cancer) 02/2024 - 03/2019
3	Squamous Cell Carcinoma of Head and Neck 06/2021 - 03/2019
2	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 12/2023
2	Carcinogenesis 01/2023 - 06/2021
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Adenocarcinoma 01/2023
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2022
1	Breast Neoplasms (Breast Cancer) 01/2022

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 12/2023 - 03/2019
4	MicroRNAs (MicroRNA)IBA 10/2023 - 03/2019
3	Proteins (Proteins, Gene)FDA Link 10/2023 - 03/2019
1	ARQ 197IBA 02/2024
1	Gemcitabine FDA Link 02/2024
1	NucleosidesIBA 02/2024
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2024
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2023
1	Glucose (Dextrose)FDA LinkGeneric 10/2023
1	Nucleic AcidsIBA 10/2023
1	EnzymesIBA 10/2023
1	AlpelisibIBA 01/2020

Therapy/Procedure

6	Therapeutics 02/2024 - 03/2019
2	Drug Therapy (Chemotherapy) 10/2023 - 03/2019
2	Immunotherapy 10/2023 - 11/2022
1	Precision Medicine 01/2022
1	Radiotherapy 03/2019